Sunitinib | compare suppliers & send inquiries for free
Looking for Sunitinib 557795-19-4?
Why are people looking for Sunitinib? Sunitinib is a small-molecule multi-targeted receptor tyrosine kinase (RTK) inhibitor. On January 26, 2006, the agent was formally approved by the US FDA for the indications of treating renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST). For these purposes, sunitinib is generally available as an orally administered formulation. Sunitinib inhibits cellular signaling by targeting multiple RTKs.
These include all platelet-derived growth factor receptors (PDGF-R) and vascular endothelial growth factor receptors (VEGF-R). Sunitinib also inhibits KIT (CD117), the RTK that drives the majority of GISTs. In addition, sunitinib inhibits other RTKs including RET, CSF-1R, and flt3.
Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.
Sunitinib manufacturers | traders | suppliers
We have 11 companies offering Sunitinib from 3 different countries.
Get in contact with the supplier of your choice:
- SENOVA Technology Co., Ltd. from China
- MSN Labs. from India
- Shilpa Medicare from India
- Mylan from India
- Hetero Labs from India
- Teva API from Israel
- Reliance Life Sciences from India
- Qilu Antibiotics from China
- Adley Formulations from India
- Beijing Lunarsun Pharma from China
- Hunan Ouya Biological Co., Ltd. from China
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.